These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15932532)

  • 21. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
    Dunkel IJ; Jubran RF; Gururangan S; Chantada GL; Finlay JL; Goldman S; Khakoo Y; O'Brien JM; Orjuela M; Rodriguez-Galindo C; Souweidane MM; Abramson DH
    Pediatr Blood Cancer; 2010 Mar; 54(3):384-7. PubMed ID: 19908299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH
    Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.
    ElZomor H; Taha H; Aleieldin A; Nour R; Zaghloul MS; Fawzi M; Kamel A; Alfaar AS
    Ophthalmic Genet; 2015; 36(3):287-9. PubMed ID: 25945688
    [No Abstract]   [Full Text] [Related]  

  • 25. Retinoblastoma CSF metastasis cured by multimodality chemotherapy without radiation.
    Dimaras H; Héon E; Budning A; Doyle JJ; Halliday W; Gallie BL; Chan HS
    Ophthalmic Genet; 2009 Sep; 30(3):121-6. PubMed ID: 19941416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nm23 expression in retinoblastoma.
    Krishnakumar S; Lakshmi A; Shanmugam MP; Vanitha K; Biswas J
    Ocul Immunol Inflamm; 2004 Jun; 12(2):127-35. PubMed ID: 15512982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary results of primary chemotherapy in retinoblastoma.
    Bornfeld N; Schüler A; Bechrakis N; Henze G; Havers W
    Klin Padiatr; 1997; 209(4):216-21. PubMed ID: 9293453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
    Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual intraretinal retinoblastoma after chemoreduction failure.
    Hwang CK; Aaberg TM; Chevez-Barrios P; Verner-Cole E; Gombos DS; Paysse E; Chintagumpala M; Gao W; Grossniklaus HE
    Arch Ophthalmol; 2012 Feb; 130(2):246-8. PubMed ID: 22332223
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
    Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifaceted chemotherapy for trilateral retinoblastoma.
    Dimaras H; Héon E; Doyle J; Strahlendorf C; Paton KE; Halliday W; Babyn P; Gallie BL; Chan HS
    Arch Ophthalmol; 2011 Mar; 129(3):362-5. PubMed ID: 21402997
    [No Abstract]   [Full Text] [Related]  

  • 32. Selective ophthalmic arterial infusion of chemotherapeutic drugs for recurrent retinoblastoma.
    Trinavarat A; Chiewvit P; Buaboonnam J; Sanpakit K; Atchaneeyasakul LO
    J Pediatr Hematol Oncol; 2012 Aug; 34(6):e218-21. PubMed ID: 22584782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The success of primary chemotherapy for group D heritable retinoblastoma.
    Cohen VM; Kingston J; Hungerford JL
    Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive treatment].
    Xue K; Qian J; Bi YW; Yao YQ; Yuan YF; DA CD
    Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):134-41. PubMed ID: 21426843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Results of combined chemotherapy and local ophtalmic therapy for intraocular retinoblastoma].
    Balwierz W; Pietrys D; Romanowska-Dixon B; Kobylarz J; Pawińska-Wasikowska K; Moryl-Bujakowska A
    Przegl Lek; 2010; 67(6):404-8. PubMed ID: 21344770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced unilateral retinoblastoma: a case of sparing enucleation treatment failure.
    Valente P; De Ioris MA; Romanzo A; Cozza R; Natali G; Buzzonetti L
    Can J Ophthalmol; 2016 Apr; 51(2):e40-3. PubMed ID: 27085272
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
    Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
    Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anterior Segment Seeding in Eyes With Retinoblastoma Failing to Respond to Intraophthalmic Artery Chemotherapy.
    Pavlidou E; Burris C; Thaung C; Scheimberg I; Kingston J; Hungerford JL; Reddy MA; Sagoo MS
    JAMA Ophthalmol; 2015 Dec; 133(12):1455-8. PubMed ID: 26334520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anterior Chamber Invasion in Retinoblastoma: Not an Indication for Adjuvant Chemotherapy.
    Sreelakshmi KV; Chandra A; Krishnakumar S; Natarajan V; Khetan V
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4654-4661. PubMed ID: 28903151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.